Analyst stock forecast
Humacyte Forecast: $1.63 Analyst Target
Direct answer
Humacyte's average price target is $1.63.
The target implies +278.8% from the recorded current price, and the consensus rating is Buy.
The low target implies +16.6%, the high target implies +832.4%, and the range spans 815.9% of the current price.
Forecast evidence checked October 17, 2026.
Get free Humacyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.43
- Average price target
- $1.63
- High price target
- $4.00
- Low price target
- $0.50
- Low target gap
- +16.6%
- Target upside
- +278.8%
- High target gap
- +832.4%
- Target range width
- 815.9%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is Humacyte's average price target?
Humacyte's verified average price target is $1.63. The target range is $0.50 to $4.00.
How far are Humacyte's low and high targets from the recorded price?
The low target implies +16.6%, while the high target implies +832.4%.
How many analysts are included in Humacyte's consensus?
The verified consensus includes 6 analysts.
How is Humacyte's target upside or downside calculated?
The average target of $1.63 is divided by the recorded price of $0.43, then one is subtracted to produce +278.8%. This does not guarantee a future return.
When was Humacyte's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.